Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Airdoc Technology Co's quarterly market cap
increased
from Dec. 2024 (HK$1,273.4 Mil) to Jun. 2025 (HK$1,316.3 Mil) but then
declined
from Jun. 2025 (HK$1,316.3 Mil) to Dec. 2025 (HK$1,171.4 Mil).
Beijing Airdoc Technology Co's annual market cap
increased
from Dec. 2023 (HK$1,240.8 Mil) to Dec. 2024 (HK$1,273.4 Mil) but then
declined
from Dec. 2024 (HK$1,273.4 Mil) to Dec. 2025 (HK$1,171.4 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beijing Airdoc Technology Co's Enterprise Value for Today is HK$112.3 Mil.
Beijing Airdoc Technology Co (HKSE:02251) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Beijing Airdoc Technology Co Market Cap Related Terms
Beijing Airdoc Technology Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02251 vs VEEV, BTSG, TEM: Market Cap Comparison
For the Health Information Services subindustry, Beijing Airdoc Technology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Airdoc Technology Co Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beijing Airdoc Technology Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Beijing Airdoc Technology Co's Market Cap falls into.
Beijing Airdoc Technology Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Airdoc Technology Co (HKSE:02251) has a Market Cap of HK$798.2 Mil as of Sep. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beijing Airdoc Technology Co and its competitors. According to the industry distribution chart, Beijing Airdoc Technology Co ranks #351 out of 690 companies in the Healthcare Providers & Services industry, placing it in the top 50.9%.
Is Beijing Airdoc Technology Co's Market Cap too high?
Beijing Airdoc Technology Co's current Market Cap is HK$798.2 Mil. Based on the distribution chart, Beijing Airdoc Technology Co ranks #351 out of 690 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Beijing Airdoc Technology Co has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Airdoc Technology Co's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Beijing Airdoc Technology Co ranks #351 out of 690 companies for Market Cap. This places Beijing Airdoc Technology Co in the lower half of its industry. The industry median Market Cap is 108.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 108.38, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beijing Airdoc Technology Co and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 108.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Airdoc Technology Co's current Market Cap is HK$798.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Airdoc Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Airdoc Technology Co (HKSE:02251) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$15.18, compared to a current price of HK$7.90 — trading 48% below its estimated fair value. The current Market Cap is HK$798.2 Mil. Beijing Airdoc Technology Co's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Beijing Airdoc Technology Co (HKSE:02251), the current Market Cap is HK$798.2 Mil as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Airdoc Technology Co (HKSE:02251) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Airdoc Technology Co stock appears to be undervalued.
The current stock price of HK$7.90 is trading 48% below its estimated GF Value™ of HK$15.18.
GuruFocus considers Beijing Airdoc Technology Co to be Significantly Undervalued.
Key valuation signals for HKSE:02251:
Market Cap: HK$798.2 Mil
GF Value™: HK$15.18 vs. price of HK$7.90 (48% below fair value)
No single metric tells the full story. See the HKSE:02251 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses, and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective, and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue from the provision of AI-based software solutions, sales of hardware devices, and other services. Geographically, the company generates the majority of its revenue from Mainland China.
64GF Score
Get the complete analysis for HKSE:02251
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02251 has been successfully added to your 
